Yahoo
NasdaqCM - Delayed Quote USD

Curanex Pharmaceuticals Inc (CURX)

6.21 0.00 (0.00%)
As of November 6 at 4:00:00 PM EST. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-12,079.09 -10,484.45 -555.58 -0.12 3.34
Cash Flow from Financing Activities
14,908.70 15,308.70 630.10 72.06 -3
Cash and Cash Equivalents, End of Period
2,938.46 4,973.13 148.89 74.37 2.43
Cash Flow, Supplemental
Free Cash Flow to Firm
-10,333.08 -4,137.17 -286.83 -17.38 0.93
Issuance of Capital Stock
0 15,655.19 630.10 69.06 0
Repurchase of Capital Stock
0 -346.50 0 0 0
Free Cash Flow to Cash Flow from Operating Activities
-- -- -- -- 1.00
12/31/2022 - 8/26/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: